Updates matching "National"

Washington, DC – The American Cancer Society Cancer Action Network (ACS CAN) launched a new advertising campaign this week highlighting its strong support for the Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 1946/S. 1873), legislation that aims to improve access to new and innovative cancer screenings among Medicare beneficiaries

The House Ways and Means Committee is expected to vote today on legislation that if enacted would greatly improve public health.

Washington, D.C.— The House Energy and Commerce Committee will vote today on legislation that would greatly improve the availability and affordability of health care for millions of Americans. The legislation—part of the broader budget reconciliation package before Congress—would create a means for low-income people living in states that have not

More than a dozen patient advocacy organizations are commending the House Ways and Means Committee as it begins considering details of legislation to create the country’s first ever national paid family and medical leave program as part of the budget reconciliation package.

Our thoughts and well wishes are with Sen. Amy Klobuchar, D-Minn., as she shares her personal journey with early-stage breast cancer. Sen. Klobuchar’s recent statements on the importance of routine screenings and follow-up are reminders that finding cancer early can give the best chance for successful treatment.

Washington, D.C.— Today the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other tobacco product manufacturers’ applications to keep their harmful products on the market. The September 9th deadline was set as the result of a 2018 lawsuit filed by

The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Departments of Health and Human Services, Labor and Treasury to put cancer patients and survivors first when implementing rules around surprise medical bills.

The U.S. Food and Drug Administration issued marketing denial orders (MDOs) to 31 companies who sought to sell 300,000 flavored electronic cigarettes. The decision requires these manufacturers to remove those identified products already on the market.

The U.S. Food and Drug Administration issued its first denials of flavored electronic cigarettes after the agency determined the manufacturer’s products pose a greater risk to public health than any potential benefit.